Latest Prescription Drugs news
Survival Benefit Seen With Triple Therapy for Severe COVID-19
posted August 11th
by modernClinician Editorial Team
by modernClinician Editorial Team
Use of Medication Therapy for Opioid Use Disorder Increased 2010 to 2019
posted August 10th
by modernClinician Editorial Team
by modernClinician Editorial Team
Few Insured Individuals Receive Timely DAA Treatment for Hep C
posted August 10th
by modernClinician Editorial Team
by modernClinician Editorial Team
FDA Approves First Targeted Therapy for HER2-Low Breast Cancer
posted August 8th
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
Drug Interactions Reducing Contraceptive Effectiveness Common in Epilepsy .jpg)
Most Specialty Oral Anticancer Meds for Blood Cancers Are Initially Rejected by Insurers 
Gap Found Between Awareness of Breast Cancer Risk and Risk-Reducing Behavior 
1 in 3 With Lupus Take Supplements, Medications With Potential for Interactions Related Articles
Holding DMARDs at Time of COVID-19 Vaccine Not Warranted in Those With Inflammatory Arthritis 
2013 to 2024 Saw Decrease in Benzodiazepine Prescribing 
Polypharmacy of Prescription Medications Increased for U.S. Older Adults 
GLP-1 Receptor Agonists, SGLT-2is Slow Renal Function Decline in T2D With Albuminuria Monthly Specialist Briefings
Stay Connected
